Functional Vascular Tissue Engineering Inspired by Matricellular Proteins
Open Access
- 31 May 2019
- journal article
- review article
- Published by Frontiers Media SA in Frontiers in Cardiovascular Medicine
- Vol. 6, 74
Abstract
Modern regenerative medicine, and tissue engineering specifically, has benefited from a greater appreciation of the native extracellular matrix (ECM). Fibronectin, collagen, and elastin have entered the tissue engineer's toolkit; however, as fully decellularized biomaterials have come to the forefront in vascular engineering it has become apparent that the ECM is comprised of more than just fibronectin, collagen, and elastin, and that cell-instructive molecules known as matricellular proteins are critical for desired outcomes. In brief, matricellular proteins are ECM constituents that contrast with the canonical structural proteins of the ECM in that their primary role is to interact with the cell. Of late, matricellular genes have been linked to diseases including connective tissue disorders, cardiovascular disease, and cancer. Despite the range of biological activities, this class of biomolecules has not been actively used in the field of regenerative medicine. The intent of this review is to bring matricellular proteins into wider use in the context of vascular tissue engineering. Matricellular proteins orchestrate the formation of new collagen and elastin fibers that have proper mechanical properties—these will be essential components for a fully biological small diameter tissue engineered vascular graft (TEVG). Matricellular proteins also regulate the initiation of thrombosis via fibrin deposition and platelet activation, and the clearance of thrombus when it is no longer needed—proper regulation of thrombosis will be critical for maintaining patency of a TEVG after implantation. Matricellular proteins regulate the adhesion, migration, and proliferation of endothelial cells—all are biological functions that will be critical for formation of a thrombus-resistant endothelium within a TEVG. Lastly, matricellular proteins regulate the adhesion, migration, proliferation, and activation of smooth muscle cells—proper control of these biological activities will be critical for a TEVG that recellularizes and resists neointimal formation/stenosis. We review all of these functions for matricellular proteins here, in addition to reviewing the few studies that have been performed at the intersection of matricellular protein biology and vascular tissue engineering.Keywords
Funding Information
- National Institutes of Health
- University of Pittsburgh
This publication has 145 references indexed in Scilit:
- Cell behavior on a CCN1 functionalized elastin-mimetic protein polymerBiomaterials, 2012
- Decorin Antagonizes IGF Receptor I (IGF-IR) Function by Interfering with IGF-IR Activity and Attenuating Downstream SignalingJournal of Biological Chemistry, 2011
- Serpina3n attenuates granzyme B-mediated decorin cleavage and rupture in a murine model of aortic aneurysmCell Death & Disease, 2011
- New insights into the pathogenesis of autosomal‐dominant cutis laxa with report of fiveELNmutationsHuman Mutation, 2011
- In vivo performance of a phospholipid‐coated bioerodable elastomeric graft for small‐diameter vascular applicationsJournal of Biomedical Materials Research Part A, 2010
- Pericytes display increased CCN2 expression upon culturingJournal of Cell Communication and Signaling, 2009
- Deficiency in Microfibril-associated Glycoprotein-1 Leads to Complex Phenotypes in Multiple Organ SystemsJournal of Biological Chemistry, 2008
- Influence of cyclic strain and decorin deficiency on 3D cellularized collagen matricesBiomaterials, 2008
- Microfibril-associate glycoprotein-2 (MAGP-2) promotes angiogenic cell sprouting by blocking notch signaling in endothelial cellsMicrovascular Research, 2008
- Peptides derived from type I thrombospondin repeat-containing proteins of the CCN family inhibit proliferation and migration of endothelial cellsThe International Journal of Biochemistry & Cell Biology, 2007